| Autor: |
Baby, Anisha, Joseph, Siby, Gireesh Kumar K. P. |
| Předmět: |
|
| Zdroj: |
International Journal of Pharma Research; Jan-Jun2015, Vol. 6 Issue 1, p22-26, 5p |
| Abstrakt: |
Lung diseases like asthma and chronic obstructive pulmonary disease (COPD) are accompanied by major burden of symptoms and health care utilization. The study aimed to identify drug related problems (DRP) in a population suffering from COPD and Asthma. Patients admitted under General medicine department with age ≥ 18 years diagnosed with either Asthma or COPD from August 2013 to August 2014 were randomly recruited for this single centre, retrospective study. Patient's demographic details and other pertinent data were collected by reviewing electronic medical records and cross checked with manually maintained medical records wherever necessary. Drug therapy of the patients was critically reviewed and analyzed for drug related problems. Among 100 study sample, 53 were asthmatic and 47 diagnosed with COPD. Approximately 70% of asthmatics were females and 75% of COPD patients were males. Major DRPs identified were drug-drug interactions (51) and adverse drug reactions (17). Among (51) interactions identified' 29 were risk rating category C and 22 risk rating D based on Lexicomp drug interaction checker where close monitoring is warranted. Other DRPs include inappropriate drug selection, inappropriate dose, inappropriate frequency and therapeutic duplication. This study shows that a significant number of the drug related problems in a population suffering from either Asthma or COPD exists. Hence, introduction of a clinical pharmacist can play an ideal role in detection, evaluation and resolution of medication related problems in association with other healthcare providers at the time of prescribing or during treatment with the ultimate aim of better therapeutic outcome. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
